Marcela Howell on Physicians’ Role in Reproductive Justice

In response to today’s Supreme Court decision to preserve telehealth access to mifepristone while Louisiana v. FDA litigation continues, Dr. Regina Davis Moss, President and CEO of IOOV, issued the following statement...

“Today’s decision is yet another dangerous escalation in this administration’s campaign to attack reproductive health care by advancing politically motivated restrictions on mifepristone. We know that Black women and gender-expansive people will bear the brunt of this outcome—not only with how we make decisions about our bodies, but with our lives.”